2021 annual financial data

Bionano Genomics, Inc. 2021 Net margin

Bionano Genomics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -402.84%.

Operating income was -77,101,000 USD and net income was -72,435,000 USD.
Operating cash flow was -71,927,000 USD.

Get free Bionano Genomics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
17,981,000 USD
Operating income
-77,101,000 USD
Net income
-72,435,000 USD
Operating cash flow
-71,927,000 USD